When Veterinary Drugs Reach Human Hospitals: A Problem-Based Learning Discussion.
Journal
A&A practice
ISSN: 2575-3126
Titre abrégé: A A Pract
Pays: United States
ID NLM: 101714112
Informations de publication
Date de publication:
01 Jul 2023
01 Jul 2023
Historique:
medline:
21
7
2023
pubmed:
18
7
2023
entrez:
18
7
2023
Statut:
epublish
Résumé
The delivery of drugs from the manufacturer to the hospital is a complex process. Despite numerous safeguards, lapses may occur, creating the potential for patient harm. Recently, an urban tertiary care medical center received a shipment of isoflurane bottles labeled for veterinary use. This error was not identified until the veterinary isoflurane reached the operating room automated medication dispensing system. No patients received the anesthetic. This report describes how such an error occurred, explains the differences between veterinary and human medications, and emphasizes the importance of vigilance in the drug supply chain to prevent patient harm.
Identifiants
pubmed: 37463288
doi: 10.1213/XAA.0000000000001705
pii: 02054229-202307000-00009
doi:
Substances chimiques
Veterinary Drugs
0
Isoflurane
CYS9AKD70P
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e01705Informations de copyright
Copyright © 2023 International Anesthesia Research Society.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Costantino RC. The U.S. medicine chest: understanding the U.S. pharmaceutical supply chain and the role of the pharmacist. J Am Pharm Assoc (2003). 2021;61:e87–e92.
Gouveia BG, Rijo P, Gonçalo TS, Reis CP. Good manufacturing practices for medicinal products for human use. J Pharm Bioallied Sci. 2015;7:87–96.
American Society of Hospital Pharmacists. ASHP guidelines: minimum standard for pharmacies in hospitals. Am J Health Syst Pharm. 2013;70:1619–1630.
Barlas S. FDA weighs updating its bar-code mandate: hospital pharmacies worry about implementation. P T. 2012;37:162–172.
Isoflurane labeled “for animal use only” in cartons of isoflurane intended for human use. Institute for Safe Medication Practices. Published January 9, 2023. Accessed February 3, 2023. https://www.ismp.org/alerts/isoflurane-labeled-animal-use-only-cartons-isoflurane-intended-human-use.
Pennsylvania Patient Safety Authority. Drug labeling and packaging-looking beyond what meets the eye: advisory. Pennsylvania Patient Safety Authority. Published September 2007. Accessed February 8, 2023. http://patientsafety.pa.gov/ADVISORIES/Pages/200709_69b.aspx.
Reason J. Human error: models and management. BMJ. 2000;320:768–770.
Davey A, Diba A. Ward’s Anaesthetic Equipment. Elsevier Health Sciences; 2012.
Hoang R, Temple C, Correia MS, Clemons J, Hendrickson RG. Characteristics of ivermectin toxicity in patients taking veterinary and human formulations for the prevention and treatment of COVID-19. Clin Toxicol (Phila). 2022;60:1350–1355.
Perrin AJ. Intentional misuse of veterinary medications in human suicide. J Vet Pharmacol Ther. 2015;38:209–213.
Anand A, Hosanagar A. Drug misuse in the veterinary setting: an under-recognized avenue. Curr Psychiatry Rep. 2021;23:3.
Hendricks B, Rudisill T, Pesarsick J, et al. Prescription drug monitoring program policy reform: human and veterinary practitioner prescribing in West Virginia, 2008–2020. J Public Health Policy. 2021;42:249–257.
Erramouspe J, Adamcik BA, Carlson RK. Veterinarian perception of the intentional misuse of veterinary medications in humans: a preliminary survey of Idaho-licensed practitioners. J Rural Health. 2002;18:311–318.
Haque W, Chencheri S, Virnig BA, et al. Price comparison of human and veterinary formulations of common medications. JAMA Intern Med. 2022;182:1216–1218.
Chamberlain CJ, Koniaris LG, Wu AW, Pawlik TM. Disclosure of “nonharmful” medical errors and other events: duty to disclose. Arch Surg. 2012;147:282–286.